Quantcast
Channel: Форумы для людей с аутоиммунными заболеваниями
Viewing all articles
Browse latest Browse all 8890

ChemoCentryx may move on with Crohn's disease drug

$
0
0
ChemoCentryx CEO Thomas Schall: Full control of the experimental Crohn's disease drug vercirnon gives company "many degrees of freedom."


More...

Viewing all articles
Browse latest Browse all 8890

Trending Articles